Compare EXEL & WES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EXEL | WES |
|---|---|---|
| Founded | 1994 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.8B | 17.3B |
| IPO Year | 2000 | 2012 |
| Metric | EXEL | WES |
|---|---|---|
| Price | $65.20 | $40.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 15 |
| Target Price | ★ $61.36 | $49.15 |
| AVG Volume (30 Days) | ★ 2.4M | 1.7M |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 9.19% |
| EPS Growth | ★ 57.95 | N/A |
| EPS | ★ 2.46 | N/A |
| Revenue | $452,477,000.00 | ★ $3,843,403,000.00 |
| Revenue This Year | $10.14 | $23.74 |
| Revenue Next Year | $12.56 | $4.39 |
| P/E Ratio | $26.76 | ★ $14.73 |
| Revenue Growth | N/A | ★ 6.61 |
| 52 Week Low | $39.71 | $38.55 |
| 52 Week High | $73.69 | $50.07 |
| Indicator | EXEL | WES |
|---|---|---|
| Relative Strength Index (RSI) | 45.48 | 32.87 |
| Support Level | $55.28 | $39.98 |
| Resistance Level | $73.69 | $42.84 |
| Average True Range (ATR) | 2.42 | 1.13 |
| MACD | -0.88 | -0.08 |
| Stochastic Oscillator | 1.60 | 18.25 |
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
Western Midstream Partners LP is a USA-based company which own, operate, acquire and develop midstream energy assets. The company through its subsidiary is engaged in the business of gathering, processing, compressing, treating and transporting natural gas, condensate, NGLs and crude oil. It owns or has investments in assets located in the Rocky Mountains (Colorado, Utah, and Wyoming), the Mid-Continent (Kansas and Oklahoma) and Texas.